Observational studyPharmacological reports : PR2025

Real‑world safety and efficacy of biological agents in inflammatory bowel disease: a one-year post-marketing pharmacovigilance observational study in the Calabria region.

Antonio Fabiano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.